Effects of Semaglutide on Albuminuria and Kidney Function in People With Overweight or Obesity With or Without Type 2 Diabetes: Exploratory Analysis From the STEP 1, 2, and 3 Trials

OBJECTIVE: These post hoc analyses of the Semaglutide Treatment Effect in People with obesity (STEP) 1–3 trials (NCT03548935, NCT03552757, and NCT03611582) explored the effects of semaglutide (up to 2.4 mg) on kidney function. RESEARCH DESIGN AND METHODS: STEP 1–3 included adults with overweight/obe...

Descripción completa

Detalles Bibliográficos
Autores principales: Heerspink, Hiddo J.L., Apperloo, Ellen, Davies, Melanie, Dicker, Dror, Kandler, Kristian, Rosenstock, Julio, Sørrig, Rasmus, Lawson, Jack, Zeuthen, Niels, Cherney, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090901/
https://www.ncbi.nlm.nih.gov/pubmed/36801984
http://dx.doi.org/10.2337/dc22-1889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090901/
https://www.ncbi.nlm.nih.gov/pubmed/36801984
http://dx.doi.org/10.2337/dc22-1889

Ejemplares similares